The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer.
Darr C, Krafft U, Hadaschik B, Tschirdewahn S, Sevcenco S, Csizmarik A, Nyirady P, Küronya Z, Reis H, Maj-Hes A, Shariat SF, Kramer G, Szarvas T.
Darr C, et al. Among authors: sevcenco s.
Urol Int. 2018;101(1):65-73. doi: 10.1159/000489891. Epub 2018 Jun 27.
Urol Int. 2018.
PMID: 29949801